Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/08/2909476/0/en/Kineta-Announces-Exclusivity-and-Right-of-First-Offer-Agreement-for-its-VISTA-blocking-antibody-with-TuHURA-Biosciences.html
https://www.globenewswire.com/news-release/2024/05/15/2882854/0/en/Kineta-Reports-First-Quarter-2024-Financial-Results-and-Provides-Update-on-its-Ongoing-Phase-1-2-VISTA-101-Clinical-Trial-and-Corporate-Activities.html
https://www.globenewswire.com/news-release/2024/04/08/2859553/0/en/Kineta-Reports-Initial-Clinical-Response-Data-at-AACR-2024-of-its-Ongoing-Phase-1-2-VISTA-101-Clinical-Trial.html
https://www.globenewswire.com/news-release/2024/03/21/2850608/0/en/Kineta-Reports-Full-Year-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com//news-release/2024/03/12/2844483/0/en/KVA12123-Clears-Additional-Cohorts-in-Monotherapy-and-in-Combination-Therapy-Arms-in-the-Phase-1-2-VISTA-101-Clinical-Trial-Initial-Clinical-Response-Data-Reported.html
https://www.globenewswire.com//news-release/2024/02/29/2837995/0/en/Kineta-Announces-Restructuring-and-Exploration-of-Strategic-Alternatives.html
https://www.fiercebiotech.com/biotech/after-saving-yumanitys-assets-kineta-faces-shut-down-private-placement-fails-show
https://www.globenewswire.com//news-release/2024/02/22/2833675/0/en/Kineta-to-Present-New-Preclinical-Data-on-its-Anti-VISTA-Antibody-KVA12123-in-Acute-Myeloid-Leukemia-at-the-AACR-Blood-Cancer-Discovery-Symposium.html
https://www.globenewswire.com//news-release/2024/02/14/2829081/0/en/Kineta-to-Present-at-Upcoming-Investor-Conferences.html
https://www.globenewswire.com//news-release/2024/02/07/2825204/0/en/Kineta-to-Participate-in-H-C-Wainwright-Virtual-Home-Fireside-Chat-Series.html